- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05689567
Anteojos enfocados en la emetropización en niños chinos
Efecto de los anteojos de enfoque periférico sobre la emetropización en niños chinos de 6 a 8 años: 2 años de ensayo clínico aleatorizado.
The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.
The study adopts a 2-year,single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Porcelana, 201110
- Children's Hospital of Fudan University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age: ≥6 and ≤8 years at enrollment.
- At least one parent' s Spherical equivalent refraction≤-3.00D.
- Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
- Astigmatism ≤1.00 D .
- Anisometropia ≤1.00 D.
- Best Corrected Visual Acuity (BCVA) : 1.0 or better
- Provision of consent written by subject's legal guardian
- Willing and able to participate in all required activities of the study
Exclusion Criteria:
- Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
- Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
- Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc.
- Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
- Noncompliance with measurement at enrollment.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: DEFOG group
Subjescts will wear DEFOG glasses(peripheral focus-out glasses). |
Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week. |
|
Sin intervención: Control group
Subjects in the control group will just be observed. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)
Periodo de tiempo: From baseline till the 24th month
|
Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes. |
From baseline till the 24th month
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes of Cycloplegic Objective Refraction(SER) (D)
Periodo de tiempo: The 6th month, the 12th month and the 18th month from baseline
|
Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month and the 18th month from baseline
|
|
Myopia
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Axial Length(AL)(mm)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Amplitude of Accommodation (AMP)(D)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Uncorrected Visual Acuity
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Strabismus Examination(△)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Strabismus examination at any follow-up time by SYNOPTOPHORE. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Choroidal Thickness (ChT) (um)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Pupil size(mm)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Pupil size at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Peripheral Retinal Refraction(D)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
The percentage of participants with fast myopic shift
Periodo de tiempo: From baseline till the 24th month
|
The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
From baseline till the 24th month
|
|
Corneal curvature(D) or radius of curvature(mm)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Astigmatism (D)
Periodo de tiempo: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The adtigmatism at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- DEFOG
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .